STAT+: Pharmalittle: Investors want CEO pay tied to global vaccine equity; FDA ordered to release more documents on Pfizer Covid shot

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda appears modest for now. We plan to promenade with the official mascot, catch up on our reading, and take a nap or three. And what about you? This is a fine time to keep warm in front of the telly or face time with friends. Or you could brave the temperatures and enjoy the great outdoors, perhaps frolic in the snow, if any landed your way. Well, whatever you do, have a grand time. But be safe, wear a mask. Enjoy, and see you soon. …

More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to tie executive compensation to vaccine equity in hopes of holding management “accountable” for contributing to a global health problem, STAT writes. In a series of letters, the investors asked the heads of the board compensation committees at Pfizer (PFE), Johnson & Johnson (JNJ), Moderna (MRNA), and AstraZeneca (AZN) to adopt goals outlined recently by the World Health Organization to ensure 70% of the global population is vaccinated by the end of 2022.

Continue to STAT+ to read the full story…